Table1 Clinicopathologic Characteristics of Patients with Metastatic CDC.
Variables | Number (%) |
|---|---|
Age(years) | Â |
 < 68 | 57 (66.3%) |
 ≥ 68 | 29 (33.7%) |
Sex | Â |
Female | 25 (29.1%) |
Male | 61 (70.9%) |
Race | Â |
Black | 19 (22.1%) |
White | 61 (70.9%) |
Other | 6 (6.98%) |
Laterality | Â |
Left | 46 (53.5%) |
Right | 40 (46.5%) |
Tumor size(cm) | Â |
IQR | 7.2 [5.0; 9.3] |
 < 7 | 39 (45.3%) |
 ≥ 7 | 47 (54.7%) |
Grade stage | Â |
Grade I | 0 (0.0%) |
Grade II | 5 (7.8%) |
Grade III | 41 (64.1%) |
Grade IV | 18 (28.1%) |
T stage | Â |
T1 | 17 (20.5%) |
T2 | 4 (4.82%) |
T3 | 48 (57.8%) |
T4 | 14 (16.9%) |
N stage | Â |
N0 | 30 (36.1%) |
N +  | 53 (63.8%) |
Surgery | Â |
Yes | 57 (66.3%) |
None | 29 (33.7%) |
Radiotherapy | Â |
Yes | 20 (23.3%) |
None/Unknown | 66 (76.7%) |
Chemotherapy | Â |
Yes | 45 (52.3%) |
No/Unknown | 41 (47.7%) |
